Summary

The UAE antibiotics market is anticipated to register growth at a steady rate during the forecast period, 2023-2027. The market growth can be attributed to the advancing pharmaceutical industry and rising prevalence of infectious diseases. Increased efforts of pharmaceutical companies in the development of novel therapies are anticipated to boost the growth of the UAE antibiotics market. Supportive government legislation and launch of new antibiotic drugs are expected to propel the market growth. Collaborations for the development of antibiotics and supportive regulatory policies to expedite the approval process and research funding are anticipated to propel the growth of the UAE antibiotics market. Antibiotics are therapeutic substances with the capacity to either kill or impair the life cycles of the bacteria responsible for diseases. Since viruses, unlike bacteria, do not have a cell wall that can be destroyed to kill the infection, antibiotics cannot be used to treat viral infections like the common cold, the flu, and other similar illnesses. Furthermore, viruses employ human cells to finish their replication process; therefore, eliminating viruses also cause serious harm to human cells. Antibodies are consequently used to treat bacterial infections.
The UAE antibiotics market is segmented by drug class, spectrum, source, route of administration, distribution channel, competitive landscape, and regional distribution. The market is further segmented based on drug class into cephalosporin, Penicillin, amoxicillin, azithromycin, clindamycin, tetracycline, and others. The penicillin segment is expected to capture the highest market share in the forecast period, 2023-2027. It is available in oral form and can be taken by mouth, or by intravenous injection, or intramuscular injection. They are used to treat bacterial infections and it does not work on viral infections.
The major market players operating in the UAE antibiotics market are Novartis UAE, Pfizer UAE, Glenmark Pharmaceuticals UAE, GlaxoSmithKline UAE, and AstraZeneca UAE.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023–2027
Objective of the Study:
• To analyze the historical growth in the market size of the UAE antibiotics from 2017 to 2021.
• To estimate and forecast the market size of UAE antibiotics market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the UAE antibiotics market based on drug class, spectrum, source, route of administration, distribution channel, region, and company.
• To identify the dominant region or segment in the UAE antibiotics market.
• To identify drivers and challenges for the UAE antibiotics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the UAE antibiotics market.
• To identify and analyze the profiles of leading players operating in the UAE antibiotics market.
• To identify key sustainable strategies adopted by market players in UAE antibiotics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of the UAE antibiotics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, UAE antibiotics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• UAE Antibiotics Market, By Drug Class:
o Cephalosporin
o Penicillin
o Amoxicillin
o Azithromycin
o Clindamycin
o Tetracycline
o Others
• UAE Antibiotics Market, By Spectrum:
o Broad Spectrum Antibiotics
o Narrow Spectrum Antibiotics
• UAE Antibiotics Market, By Source:
o Natural
o Semisynthetic
o Synthetic
• UAE Antibiotics Market, By Route of Administration:
o Oral
o Intravenous
• UAE Antibiotics Market, By Distribution Channel:
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• UAE Antibiotics Market, By Region:
o Abu Dhabi
o Dubai
o Sharjah
o Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE antibiotics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on UAE Antibiotics Market
4. Voice of Customer
5. Executive Summary
6. UAE Antibiotics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class (Cephalosporin, Penicillin, Amoxicillin, Azithromycin, Clindamycin, Tetracycline, Others)
6.2.2. By Spectrum (Broad Spectrum Antibiotics v/s Narrow Spectrum Antibiotics)
6.2.3. By Source (Natural, Semisynthetic, Synthetic)
6.2.4. By Route of Administration (Oral v/s Intravenous)
6.2.5. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
6.2.6. By Company (2021)
6.2.7. By Region
6.3. Product Market Map
7. UAE Broad Spectrum Antibiotics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Source
7.2.3. By Route of Administration
7.2.4. By Distribution Channel
8. UAE Narrow Spectrum Antibiotics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Source
8.2.3. By Route of Administration
8.2.4. By Distribution Channel
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. UAE Economic Profile
13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Novartis UAE
13.2.2. Pfizer UAE
13.2.3. Glenmark Pharmaceuticals UAE
13.2.4. GlaxoSmithKline UAE
13.2.5. AstraZeneca UAE
14. Strategic Recommendations